Scolaris Content Display Scolaris Content Display

Cochrane Database of Systematic Reviews

Single dose oral celecoxib for acute postoperative pain in adults

Información

DOI:
https://doi.org/10.1002/14651858.CD004233.pub4Copiar DOI
Base de datos:
  1. Cochrane Database of Systematic Reviews
Versión publicada:
  1. 22 octubre 2013see what's new
Tipo:
  1. Intervention
Etapa:
  1. Review
Grupo Editorial Cochrane:
  1. Grupo Cochrane de Dolor y cuidados paliativos

Copyright:
  1. Copyright © 2019 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

Cifras del artículo

Altmetric:

Citado por:

Citado 0 veces por enlace Crossref Cited-by

Contraer

Autores

Contributions of authors

JB, JR, and RAM undertook searches, extracted and analysed the data for the first review.

SD and RAM carried out searches, data extraction, analysis, and writing for both earlier updates.

TW and SD carried out searches, data extraction and analysis, and updated this review. RAM checked all stages.

Sources of support

Internal sources

  • Oxford Pain Relief Trust, UK.

    General institutional support

External sources

  • No sources of support supplied

Declarations of interest

SD and TW have no interests to declare. RAM has consulted for various pharmaceutical companies and received lecture fees from pharmaceutical companies related to analgesics and other healthcare interventions. SD and RAM have received research support from charities, government, and industry sources at various times; no such support was received for this work.

Acknowledgements

Tom Weir (work experience student) helped with all aspects of this update.

This update was supported by funds from the Oxford Pain Relief Trust. Earlier updates were supported by the NHS Cochrane Collaboration Programme Grant Scheme.

Jodie Barden, Jane Edwards, and Henry McQuay were involved in the earlier reviews.

Version history

Published

Title

Stage

Authors

Version

2013 Oct 22

Single dose oral celecoxib for acute postoperative pain in adults

Review

Sheena Derry, R Andrew Moore

https://doi.org/10.1002/14651858.CD004233.pub4

2012 Mar 14

Single dose oral celecoxib for acute postoperative pain in adults

Review

Sheena Derry, R Andrew Moore

https://doi.org/10.1002/14651858.CD004233.pub3

2008 Oct 08

Single dose oral celecoxib for acute postoperative pain in adults

Review

Sheena Derry, Jodie Barden, Henry J McQuay, R Andrew Moore

https://doi.org/10.1002/14651858.CD004233.pub2

2003 Jan 20

Single dose oral celecoxib for postoperative pain

Review

Jodie Barden, Jayne Edwards, Henry HJ McQuay, R A Moore, Andrew Moore

https://doi.org/10.1002/14651858.CD004233

Notes

At December 2016, this review has been stabilised following discussion with the authors and editors. If appropriate, we will update the review if new evidence likely to change the conclusions is published, or if standards change substantially which necessitate major revisions. New searches in November 2016 did not identify any studies that would affect the conclusions of the review. In one single‐dose study in dental pain and two multiple‐dose studies in bunionectomy, celecoxib 400 mg was used as an active comparator for submicron formulations of diclofenac and indomethacin. Results for celecoxib versus placebo were consistent with the review findings.

Keywords

MeSH

PICO

Population
Intervention
Comparison
Outcome

El uso y la enseñanza del modelo PICO están muy extendidos en el ámbito de la atención sanitaria basada en la evidencia para formular preguntas y estrategias de búsqueda y para caracterizar estudios o metanálisis clínicos. PICO son las siglas en inglés de cuatro posibles componentes de una pregunta de investigación: paciente, población o problema; intervención; comparación; desenlace (outcome).

Para saber más sobre el uso del modelo PICO, puede consultar el Manual Cochrane.

Flow diagram.
Figuras y tablas -
Figure 1

Flow diagram.

'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies.
Figuras y tablas -
Figure 2

'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies.

'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study.
Figuras y tablas -
Figure 3

'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study.

Forest plot of comparison: 1 Celecoxib 200 mg versus placebo, outcome: 1.1 At least 50% pain relief over 4‐6 hours.
Figuras y tablas -
Figure 4

Forest plot of comparison: 1 Celecoxib 200 mg versus placebo, outcome: 1.1 At least 50% pain relief over 4‐6 hours.

L'Abbé plot of celecoxib 200 mg versus placebo for at least 50% pain relief. Size of circle is proportional to size of study (inset scale). Cream circles ‐ dental studies; pink circle ‐ orthopaedic study.
Figuras y tablas -
Figure 5

L'Abbé plot of celecoxib 200 mg versus placebo for at least 50% pain relief. Size of circle is proportional to size of study (inset scale). Cream circles ‐ dental studies; pink circle ‐ orthopaedic study.

Forest plot of comparison: 2 Celecoxib 400 mg versus placebo, outcome: 2.1 At least 50% pain relief over 4‐6 hours dental pain.
Figuras y tablas -
Figure 6

Forest plot of comparison: 2 Celecoxib 400 mg versus placebo, outcome: 2.1 At least 50% pain relief over 4‐6 hours dental pain.

L'Abbé plot of celecoxib 400 mg versus placebo for at least 50% pain relief. Size of circle is proportional to size of study (inset scale). Cream circles ‐ dental studies
Figuras y tablas -
Figure 7

L'Abbé plot of celecoxib 400 mg versus placebo for at least 50% pain relief. Size of circle is proportional to size of study (inset scale). Cream circles ‐ dental studies

Comparison 1 Celecoxib 200 mg versus placebo, Outcome 1 At least 50% pain relief over 4‐6 hours.
Figuras y tablas -
Analysis 1.1

Comparison 1 Celecoxib 200 mg versus placebo, Outcome 1 At least 50% pain relief over 4‐6 hours.

Comparison 1 Celecoxib 200 mg versus placebo, Outcome 2 Use of rescue medication over 24 hours.
Figuras y tablas -
Analysis 1.2

Comparison 1 Celecoxib 200 mg versus placebo, Outcome 2 Use of rescue medication over 24 hours.

Comparison 1 Celecoxib 200 mg versus placebo, Outcome 3 Any adverse event.
Figuras y tablas -
Analysis 1.3

Comparison 1 Celecoxib 200 mg versus placebo, Outcome 3 Any adverse event.

Comparison 2 Celecoxib 400 mg versus placebo, Outcome 1 At least 50% pain relief over 4‐6 hours, dental pain.
Figuras y tablas -
Analysis 2.1

Comparison 2 Celecoxib 400 mg versus placebo, Outcome 1 At least 50% pain relief over 4‐6 hours, dental pain.

Comparison 2 Celecoxib 400 mg versus placebo, Outcome 2 Use of rescue medication over 24 hours.
Figuras y tablas -
Analysis 2.2

Comparison 2 Celecoxib 400 mg versus placebo, Outcome 2 Use of rescue medication over 24 hours.

Comparison 2 Celecoxib 400 mg versus placebo, Outcome 3 Any adverse event.
Figuras y tablas -
Analysis 2.3

Comparison 2 Celecoxib 400 mg versus placebo, Outcome 3 Any adverse event.

Comparison 1. Celecoxib 200 mg versus placebo

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 At least 50% pain relief over 4‐6 hours Show forest plot

4

705

Risk Ratio (M‐H, Fixed, 95% CI)

3.49 [2.40, 5.06]

1.1 Dental pain

3

423

Risk Ratio (M‐H, Fixed, 95% CI)

15.86 [5.14, 48.99]

1.2 Postsurgical pain

1

282

Risk Ratio (M‐H, Fixed, 95% CI)

1.83 [1.26, 2.68]

2 Use of rescue medication over 24 hours Show forest plot

2

271

Risk Ratio (IV, Fixed, 95% CI)

0.78 [0.70, 0.86]

3 Any adverse event Show forest plot

4

669

Risk Ratio (M‐H, Fixed, 95% CI)

0.90 [0.63, 1.29]

3.1 Dental

3

387

Risk Ratio (M‐H, Fixed, 95% CI)

0.97 [0.63, 1.49]

3.2 Orthopaedic

1

282

Risk Ratio (M‐H, Fixed, 95% CI)

0.8 [0.43, 1.48]

Figuras y tablas -
Comparison 1. Celecoxib 200 mg versus placebo
Comparison 2. Celecoxib 400 mg versus placebo

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 At least 50% pain relief over 4‐6 hours, dental pain Show forest plot

5

722

Risk Ratio (M‐H, Fixed, 95% CI)

10.26 [5.70, 18.47]

2 Use of rescue medication over 24 hours Show forest plot

3

518

Risk Ratio (IV, Fixed, 95% CI)

0.68 [0.62, 0.74]

3 Any adverse event Show forest plot

6

725

Risk Ratio (M‐H, Fixed, 95% CI)

1.00 [0.84, 1.17]

Figuras y tablas -
Comparison 2. Celecoxib 400 mg versus placebo